🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.320
-0.060 (-2.52%)
At close: Nov 20, 2026, 4:00 PM EST
2.300
-0.020 (-0.86%)
After-hours: Nov 20, 2026, 4:38 PM EST

Boundless Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
24.118.711812.169.316.02
Research & Development
34.9644.8555.2742.6437.1619.28
Operating Expenses
59.0663.5573.2754.846.4725.3
Operating Income
-59.06-63.55-73.27-54.8-46.47-25.3
Interest & Investment Income
3.35.367.895.280.670.1
Other Non Operating Income (Expenses)
0.27-00.010.08-0.1-0.01
Pretax Income
-55.5-58.2-65.36-49.43-45.9-25.21
Net Income
-55.5-58.2-65.36-49.43-45.9-25.21
Net Income to Common
-55.5-58.2-65.36-49.43-45.9-25.21
Net Income Growth
------
Shares Outstanding (Basic)
232217111
Shares Outstanding (Diluted)
232217111
Shares Change
0.85%31.65%1296.71%10.77%27.56%-
EPS (Basic)
-2.46-2.60-3.85-40.65-41.81-29.29
EPS (Diluted)
-2.46-2.60-3.85-40.65-41.81-29.29
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-57.4-47.21-63.38-47.49-40.66-25.28
Free Cash Flow Per Share
-2.55-2.11-3.73-39.05-37.04-29.38
EBITDA
-57.12-62.3-72.18-53.84-45.53-24.62
D&A For EBITDA
1.951.251.090.960.940.68
EBIT
-59.06-63.55-73.27-54.8-46.47-25.3
SEC Filings: 10-K · 10-Q